Spanish missionary in Liberia tests positive for Ebola

A Spanish missionary working in Liberia has tested positive for the deadly Ebola virus, the aid organisation he works for said Tuesday.

Miguel Pajares, a 75-year-old Roman Catholic priest, tested positive for the disease at a hospital in the Liberian capital Monrovia where he worked, Spanish charity Juan Ciudad ONGD said in a statement.

He has worked in Liberia for over five decades, the last seven years at the Saint Joseph Hospital in Monrovia.

Pajares has been in quarantine at the hospital along with five other missionaries since the death on Saturday of its director from Ebola.

Two other women who were also in quarantine, one from Congo and the other from Guinea, also tested positive for Ebola, the aid organisation said.

During an interview broadcast on Monday, Pajares said he and the other missionaries in quarantine would like to be taken to Spain for treatment.

"I have a fever. I don't have any appetite, I could go without eating anything, I have a lot of pain in my joints. I need help to move from one place to the other," he told CNN en Espanol, a 24-hour Spanish-language news network.

"We hope that we can be evacuated. For us it would be a huge joy because if we are taken to Spain we would be in good hands and we could get better, God willing," he added.

Two Americans who worked for Christian aid agencies in Liberia and were infected with Ebola while taking care of patients in Monrovia were brought back to the United States for treatment in recent days.

Over 1,600 people who have been infected with the in West Africa since March, marking the largest outbreak of Ebola in history.

A total of 887 people have died of the virus in Sierra Leone, Liberia, Guinea and Nigeria, a 55 percent fatality rate, according to the World Health Organisation.

The World Bank has pledged up to $200 million to Guinea, Liberia and Sierra Leone to help contain the outbreak.

Ebola is transmitted through close contact with bodily fluids, and people who live with or care for patients are most at risk.

add to favorites email to friend print save as pdf

Related Stories

5 things to know about Ebola outbreak in W. Africa

Jul 28, 2014

(AP)—There has been panic and fear about the deadly Ebola disease spreading ever since Nigerian health officials reported Friday that a Liberian man sick with the disease had traveled to Togo and then Nigeria ...

Recommended for you

Evidence-based recs issued for systemic care in psoriasis

8 hours ago

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

8 hours ago

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

9 hours ago

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

Discovery of genes that predispose a severe form of COPD

11 hours ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

On the environmental trail of food pathogens

12 hours ago

Tracking one of the deadliest food contamination organisms through produce farms and natural environments alike, Cornell microbiologists are showing how to use big datasets to predict where the next outbreak could start.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.